Juan Hernandez-Prera, MD

Moffitt Cancer Center
Tampa, Florida, United States

Disclosure information not submitted.

Presentation(s):

• SAT-364 - Clinical Response to Selpercatinib in Metastatic Medullary Thyroid Carcinoma with RABEP2-RET Fusion

  Saturday, June 13, 2026
  9:30 AM - 4:30 PM CT